Swallowing Disorders disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: SWL001 MIFTS: 37	Swallowing Disorders Categories: Gastrointestinal diseases, Neuronal diseases	Data Licensing For inquiries, contact: [email protected]
Tissues Related diseases Publications Symptoms & Phenotypes Drugs Expand all tables

Sources

Aliases & Classifications for Swallowing Disorders

MalaCards integrated aliases for Swallowing Disorders:

Name: Swallowing Disorders ⁵² ⁴¹

Deglutition Disorders ⁷¹

Classifications:

MalaCards categories:
Anatomical: Gastrointestinal diseases Neuronal diseases

See all MalaCards categories (disease lists)

External Ids:

UMLS ⁷¹ C0011168

Sources

Summaries for Swallowing Disorders

NINDS: ⁵² Having trouble swallowing (dysphagia) is a symptom that accompanies a number of neurological disorders. The problem can occur at any stage of the normal swallowing process as food and liquid move from the mouth, down the back of the throat, through the esophagus and into the stomach. Difficulties can range from a total inability to swallow, to coughing or choking because the food or liquid is entering the windpipe, which is referred to as aspiration. When aspiration is frequent a person can be at risk of developing pneumonia. Food may get "stuck" in the throat or individuals may drool because they cannot swallow their saliva. Neurological conditions that can cause swallowing difficulties are: stroke (the most common cause of dysphagia); traumatic brain injury; cerebral palsy; Parkinson disease and other degenerative neurological disorders such as amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), multiple sclerosis, progressive supranuclear palsy, Huntington disease, and myasthenia gravis. Muscular dystrophy and myotonic dystrophy are accompanied by dysphagia, which is also the cardinal symptom of oculopharyngeal muscular dystrophy, a rare, progressive genetic disorder.

MalaCards based summary: Swallowing Disorders, also known as deglutition disorders, is related to traumatic brain injury and cleft larynx, posterior, and has symptoms including nausea and vomiting, constipation and vomiting. The drugs Remifentanil and Acetaminophen have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, brain and tongue.

MedlinePlus: ⁴¹ If you have a swallowing disorder, you may have difficulty or pain when swallowing. Some people cannot swallow at all. Others may have trouble swallowing liquids, foods, or saliva. This makes it hard to eat. Often, it can be difficult to take in enough calories and fluids to nourish your body. Anyone can have a swallowing disorder, but it is more common in older adults. It often happens because of other conditions, including: Nervous system disorders, such as Parkinson's disease and cerebral palsy Problems with your esophagus, including GERD (gastroesophageal reflux disease) Stroke Head or spinal cord injury Cancer of the head, neck, or esophagus Medicines can help some people, while others may need surgery. Swallowing treatment with a speech-language pathologist can help. You may find it helpful to change your diet or hold your head or neck in a certain way when you eat. In very serious cases, people may need feeding tubes. NIH: National Institute on Deafness and Other Communication Disorders

Sources

Related Diseases for Swallowing Disorders

Diseases related to Swallowing Disorders via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 111)

#	Related Disease	Score
1	traumatic brain injury	11.0
2	cleft larynx, posterior	10.9
3	laryngotracheoesophageal cleft type 2	10.9
4	aspiration pneumonia	10.4
5	nutritional deficiency disease	10.3
6	parkinson disease, late-onset	10.3
7	head and neck cancer	10.3
8	stroke, ischemic	10.3
9	gastroesophageal reflux	10.2
10	cerebral palsy	10.2
11	neuromuscular disease	10.2
12	cerebrovascular disease	10.2
13	speech and communication disorders	10.1
14	papillon-lefevre syndrome	10.1
15	aphasia	10.1
16	parkinsonism	10.1
17	pneumonia	10.1
18	aplasia of lacrimal and salivary glands	10.0
19	respiratory failure	10.0
20	myopathy	10.0
21	dystonia	10.0
22	oropharynx cancer	10.0
23	speech disorder	10.0
24	lip and oral cavity cancer	10.0
25	ocular motor apraxia	9.9
26	pierre robin syndrome	9.9
27	sjogren syndrome	9.9
28	squamous cell carcinoma, head and neck	9.9
29	esophageal atresia	9.9
30	dementia	9.9
31	reading disorder	9.9
32	duodenal ulcer	9.9
33	larynx cancer	9.9
34	laryngeal benign neoplasm	9.9
35	alcohol dependence	9.8
36	apnea, obstructive sleep	9.8
37	autoimmune disease	9.8
38	machado-joseph disease	9.8
39	esophageal cancer	9.8
40	huntington disease	9.8
41	inclusion body myositis	9.8
42	lymphatic malformation 5	9.8
43	myotonic dystrophy 1	9.8
44	oculodentodigital dysplasia	9.8
45	oculopharyngeal muscular dystrophy	9.8
46	rheumatoid arthritis	9.8
47	schizophrenia	9.8
48	tracheoesophageal fistula with or without esophageal atresia	9.8
49	down syndrome	9.8
50	charge syndrome	9.8

Comorbidity relations with Swallowing Disorders via Phenotypic Disease Network (PDN): (show top 50) (show all 59)

Active Peptic Ulcer Disease	Acute Cystitis
Acute Kidney Failure	Alzheimer Disease, Familial, 1
Bronchitis	Bronchopneumonia
Cerebral Atherosclerosis	Cerebral Degeneration
Cerebrovascular Disease	Conjunctivitis
Decubitus Ulcer	Deficiency Anemia
Dyskinesia of Esophagus	Encephalopathy
Epilepsy, Focal, with Speech Disorder and with or Without Impaired Intellectual Development	Esophageal Cancer
Esophageal Candidiasis	Esophageal Disease
Esophagitis	Facial Paralysis
Familial Atrial Fibrillation	Generalized Atherosclerosis
Heart Disease	Hypertension, Essential
Hypothyroidism	Intermittent Claudication
Intracranial Embolism	Intracranial Thrombosis
Iron Deficiency Anemia	Kidney Disease
Kwashiorkor	Larynx Cancer
Major Depressive Disorder	Malignant Essential Hypertension
Marasmus	Megaesophagus
Neurogenic Bladder	Neuromuscular Disease
Nutritional Deficiency Disease	Obstructive Hydrocephalus
Ocular Motor Apraxia	Oral Candidiasis
Osteoporosis	Paralytic Ileus
Parkinson Disease, Late-Onset	Peripheral Vascular Disease
Pharyngitis	Pharynx Cancer
Progressive Bulbar Palsy	Protein-Energy Malnutrition

Graphical network of the top 20 diseases related to Swallowing Disorders:

Sources

Symptoms & Phenotypes for Swallowing Disorders

UMLS symptoms related to Swallowing Disorders:

nausea and vomiting; constipation; vomiting; abdominal pain; headache; diarrhea; nausea; odynophagia; pseudobulbar signs; dyspepsia; icterus; seizures; signs and symptoms, digestive; heartburn; gastrointestinal gas; digestive system symptom; flatulence, eructation, and gas pain; symptoms involving digestive system; other symptoms involving digestive system; pain in esophagus (finding); absent deglutition; swallowing problems; choking sensation; symptom as reason for upper g.i. examination; dysphagia, pharyngeal phase; dysphagia, pharyngoesophageal phase

Sources

Drugs & Therapeutics for Swallowing Disorders

Drugs for Swallowing Disorders (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 143)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Remifentanil

Approved

Phase 4

132875-61-7

60815

Acetaminophen

Approved

Phase 4

103-90-2

1983

Buspirone

Approved, Investigational

Phase 4

36505-84-7

2477

Oxycodone

Approved, Illicit, Investigational

Phase 4

76-42-6

5284603

Lisinopril

Approved, Investigational

Phase 4

83915-83-7, 76547-98-3

5362119

Analgesics

Phase 4

Antipyretics

Phase 4

Analgesics, Non-Narcotic

Phase 4

Carboxymethylcellulose Sodium

Phase 4

Serotonin Receptor Agonists

Phase 4

HIV Protease Inhibitors

Phase 4

protease inhibitors

Phase 4

Protective Agents

Phase 4

Cardiotonic Agents

Phase 4

Antihypertensive Agents

Phase 4

Angiotensin-Converting Enzyme Inhibitors

Phase 4

Rabeprazole

Approved, Investigational

Phase 2, Phase 3

117976-89-3, 117976-90-6

5029

Cisplatin

Approved

Phase 3

15663-27-1

2767 5702198 441203

Zinc cation

Approved, Experimental, Investigational

Phase 3

7440-66-6, 23713-49-7

32051

Fluorouracil

Approved

Phase 3

51-21-8

3385

Ketorolac

Approved

Phase 3

74103-06-3, 66635-83-4

3826

Acetylcholine

Approved, Investigational

Phase 2, Phase 3

51-84-3

187

Nicergoline

Approved, Investigational

Phase 3

27848-84-6

34040

Carnosine

Experimental, Investigational

Phase 3

305-84-0, 107667-60-7

439224

Antimetabolites

Phase 3

Immunosuppressive Agents

Phase 3

Immunologic Factors

Phase 3

Antirheumatic Agents

Phase 3

Cyclooxygenase Inhibitors

Phase 3

Anti-Inflammatory Agents, Non-Steroidal

Phase 3

Adrenergic Agents

Phase 3

abobotulinumtoxinA

Phase 2, Phase 3

Botulinum Toxins, Type A

Phase 2, Phase 3

Botulinum Toxins

Phase 2, Phase 3

Cholinergic Agents

Phase 2, Phase 3

Adrenergic Antagonists

Phase 3

Adrenergic alpha-Antagonists

Phase 3

Vasodilator Agents

Phase 3

Nootropic Agents

Phase 3

Menthol

Approved, Experimental

Phase 2

1490-04-6, 2216-51-5, 15356-60-2

1254 16666 165675

Prucalopride

Approved

Phase 2

179474-81-8

3052762

Modafinil

Approved, Investigational

Phase 2

68693-11-8

4236

Carboplatin

Approved

Phase 2

41575-94-4

10339178 38904

Paclitaxel

Approved, Vet_approved

Phase 2

33069-62-4

36314

Lidocaine

Approved, Vet_approved

Phase 2

137-58-6

3676

Glycerin

Approved, Investigational

Phase 2

56-81-5

753

Capsaicin

Approved

Phase 2

404-86-4

1548943

Amifostine

Approved, Investigational

Phase 2

20537-88-6

2141

Piperine

Investigational

Phase 1, Phase 2

94-62-2

638024

Cytochrome P-450 Enzyme Inhibitors

Phase 1, Phase 2

Interventional clinical trials:

(show top 50) (show all 413)

#	Name	Status	NCT ID	Phase	Drugs
1	Does Opioid Induced Swallowing Difficulty Lead to Elevated Risk for Pulmonary Aspiration?	Completed	NCT01495377	Phase 4	Remifentanil;Placebo;Technetium
2	Effect of Pharyngeal Inhibition Induced by Repetitive Transcranial Stimulation in Post Stroke Dysphagia	Completed	NCT01081444	Phase 4
3	Evaluation of Two Different Thickening Products in Patients With Dysphagia	Completed	NCT01651975	Phase 4
4	Neuromuscular Electroestimulation and Respiratory Muscle Training in the Management of Dysphagia of Subacute Stroke Patients	Completed	NCT02473432	Phase 4
5	Efficacy of IV vs Oral Administration of Acetaminophen for Pain Control Following Tonsillectomy With or Without Adenoidectomy	Completed	NCT01721486	Phase 4	IV acetaminophen;PO acetaminophen
6	Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft	Completed	NCT01507207	Phase 4
7	Impact of Single Dose Perioperative Steroids on Dysphagia Following Anterior Cervical Spine Surgery: A Randomized, Prospective, Double-Blind Study	Recruiting	NCT03711474	Phase 4	Dexamethasone;Saline
8	The Effect of Oral Buspirone Hydrochloride on Esophageal Motility, Bolus Transit and Symptoms of Dysphagia, in Patients With Poor Esophageal Motility: A Randomized, Double-blind, Placebo Controlled, Cross-over Trial With HRiM	Recruiting	NCT05629325	Phase 4	Buspirone Hydrochloride 10 MG;Placebo
9	Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills	Terminated	NCT03588806	Phase 4	Xtampza ER (oxycodone)
10	A Randomized Placebo Controlled Trial of Low Dose Angiotensin Converting Enzyme Inhibitor to Prevent Pneumonia in Older People Who Require Tube Feeding Because of Neurological Dysphagia	Terminated	NCT02358642	Phase 4	Angiotensin converting enzyme inhibitor (Lisinopril);Placebo
11	Impact of Early Percutaneous Tracheostomy on the Incidence of Swallowing Dysfunction in Critically Ill Patients on Mechanical Ventilation. A Randomized Clinical Trial	Unknown status	NCT01268423	Phase 3
12	The Comparison of Value of Brachytherapy and Endoscopic Stenting With SEMS in Palliative Treatment of Dysphagia Resulting From Adenocarcinoma of the Esophago-Gastric Junction	Unknown status	NCT01786278	Phase 2, Phase 3
13	A Randomised Controlled Trial of Dysphagia Therapies for Swallowing Disorders Following Stroke.	Completed	NCT00257764	Phase 2, Phase 3
14	The Effects of Intraoperative Local and Systemic Corticosteroid Administration on Postoperative Dysphagia After Anterior Cervical Fusion	Completed	NCT03311425	Phase 3	Methylprednisolone;Dexamethasone
15	A Randomized, Prospective Trial of Electrosurgical Incision Followed by Rabeprazole Versus Bougie Dilation Followed by Rabeprazole of Symptomatic Lower Esophageal (Schatzki's) Rings	Completed	NCT00204750	Phase 2, Phase 3
16	A Randomised Phase III Study in Advanced Oesophageal Cancer to Compare Quality of Life and Palliation of Dysphagia in Patients Treated With Radiotherapy vs ChemoRadiotherapy.	Completed	NCT00193882	Phase 3	Cisplatin;5-Fluorouracil
17	Study for the Evaluation of the Impact of HEPILOR on the Possible Delay in the Development of Dysphagia in Breast Cancer Patients Undergoing Adjuvant Radiotherapy on the Breast/Thoracic Wall and Lymph Node Drainage.	Completed	NCT03997188	Phase 3
18	Muscle Preservation and Swallow Function Following Radiotherapy: A Dose Response Study	Completed	NCT01279837	Phase 2, Phase 3
19	A Randomized Controlled Trial of NMES vs. Traditional Dysphagia Therapy After Stroke	Completed	NCT01279824	Phase 2, Phase 3
20	The Effect of Intravenous Non-steroidal Anti-inflammatory Drugs and Intravenous Corticosteroids on the Likelihood of Dysphagia and Dysphonia Following Anterior Cervical Discectomy and Fusion	Not yet recruiting	NCT04650893	Phase 3	Intravenous Ketorolac;Intravenous Dexamethasone;Placebo
21	Efficacy and Safety of Onabotulinum Toxin A (Botox) Injections in the Upper Esophageal Sphincter for the Treatment of Pharyngo-esophageal Dysphagia Due to Cricopharyngeal Dysfunction- A Randomized Double Blinded Placebo Controlled Trial	Not yet recruiting	NCT04695600	Phase 2, Phase 3	Botulinum Toxin Type A Injection [Botox]
22	The Study of Efficacy on Low Dose Nicergoline in Dysphagia Patients Compares With High Dose Nicergoline.	Not yet recruiting	NCT05551182	Phase 3	Nicergoline
23	Evaluation of Transcutaneous Electrical Stimulation in Post Stroke Dysphagia	Terminated	NCT01971320	Phase 3
24	Effect of Intravenous Corticosteroid Injections on Dysphagia After Anterior Cervical Spine Surgery: a Randomized, Double-blind, Placebo-controlled Study	Terminated	NCT02266797	Phase 3	Dexamethasone
25	Effectiveness of Acupuncture-like Transcutaneous Nerve Stimulation (ALTENS) in Improving Dysphagia and Associated Symptoms of Chemotherapy and/or Intensity Modulated Radiation Therapy (IMRT) for Head and Neck Cancers: A Pilot Study	Unknown status	NCT01697891	Phase 1, Phase 2
26	Phase 2 Study of rTMS on Poststroke Dysphagia	Unknown status	NCT02090231	Phase 2
27	Swallowing Rehabilitation of Dysphagic Tracheostomized Patients Under Mechanical Ventilation at Intensive Care Unit	Unknown status	NCT01496924	Phase 2
28	Randomized Phase II Trial: Swallowing Speech Pathology Intervention During Radiochemotherapy on Patients With Head and Neck Cancer	Completed	NCT02075385	Phase 2
29	Effect of Oral Menthol on the Swallow Response of Patients With Oropharyngeal Dysphagia Associated With Neurological Diseases and Aging	Completed	NCT03050957	Phase 2
30	Effect of Natural Agonists of TRPV1 in the Treatment of Functional Oropharyngeal Dysphagia in Neurological Diseases and the Elderly: Piperine	Completed	NCT01383694	Phase 1, Phase 2	Piperine
31	Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of Myoblasts	Completed	NCT00773227	Phase 2
32	Efficacy of Functional Electrical Stimulation in Dysphagia of Nasopharyngeal Cancer Post Radiotherapy	Completed	NCT00815087	Phase 2
33	Effects of Age and Age-Related Diseases on Swallowing	Completed	NCT00038350	Phase 2
34	Respiratory-Swallow Training in Veterans With Oropharyngeal Cancer	Completed	NCT01032928	Phase 2
35	Treatment of Dysphagia Using the Mendelsohn Maneuver	Completed	NCT00592761	Phase 1, Phase 2
36	Treatment of Dysphagia and Ineffective Esophageal Motility With Prucalopride: A Pilot Study	Completed	NCT03244553	Phase 2	Prucalopride
37	Pilot Study of Transcranial Direct Current Stimulation for Facilitating Swallowing Improvement After an Acute Unilateral Hemispheric Infarction	Completed	NCT01132066	Phase 1, Phase 2
38	Identifying and Treating Arousal Related Deficits in Neglect and Dysphagia	Completed	NCT01085903	Phase 2	Modafinil;Placebo
39	A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia	Completed	NCT00376506	Phase 2
40	Swallow Exercise as Prophylaxis of Dysphagia After Radiotherapy	Completed	NCT00332865	Phase 1, Phase 2
41	Induction of Volitional Swallowing in Chronic Dysphagia Post Stroke: A Novel Mechanism-Based Intervention	Completed	NCT00306501	Phase 2
42	A Phase 2 Study to Evaluate the Efficacy and Safety of Palifermin (Recombinant Human Keratinocyte Growth Factor) in the Reduction of Dysphagia in Patients Receiving Concurrent Chemoradiotherapy Followed by Consolidation Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)	Completed	NCT00094861	Phase 2	Palifermin;Placebo;Paclitaxel;Carboplatin
43	Phase II Randomized Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy Induced Esophagitis-Related Pain During the Treatment of Lung Cancer	Completed	NCT01262560	Phase 2	Manuka honey in liquid form;Manuka honey in lozenge form;Standard supportive care
44	Tongue Pressure Profile Training for Dysphagia Post Stroke	Completed	NCT01370083	Phase 2
45	Effect of Afferent Oropharyngeal Pharmacological and Electrical Stimulation on Swallow Response and on Activation of Human Cortex in Stroke Patients With Oropharyngeal Dysphagia (OD). A Randomized Controlled Trial.	Completed	NCT01777672	Phase 2
46	Effectiveness of a New Neuromuscular Electrical Stimulation (NMES) Treatment Technique (VitalStim® Therapy) in the Management of Young Infants With Severe Dysphagia: a Prospective Pilot Study	Completed	NCT01723358	Phase 2
47	Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial	Completed	NCT02927691	Phase 2
48	A Multi-Center, Double-Blind, Randomized Placebo-Controlled Investigation of Autologous Muscle Derived Cells (AMDC) for the Treatment of Tongue Dysphagia Resulting From the Treatment of Head and Neck Cancer	Recruiting	NCT05421689	Phase 1, Phase 2
49	Impacts of an Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model to Prevent Swallowing Disorders in Patients Treated With Chemoradiotherapy for Head and Neck Cancer	Not yet recruiting	NCT05621889	Phase 1, Phase 2
50	A Multicenter, Randomized, Double-blind, Double-dummy, Positive Drug Parallel Controlled Phase II Clinical Trial to Evaluate Efficacy and Safety of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis	Not yet recruiting	NCT05604261	Phase 2	Anaprazole sodium 40 mg;Anaprazole sodium 60 mg;Rabeprazole sodium 20 mg

Search NIH Clinical Center for Swallowing Disorders

Sources

Genetic Tests for Swallowing Disorders

Sources

Anatomical Context for Swallowing Disorders

Organs/tissues related to Swallowing Disorders:

MalaCards : Spinal Cord, Brain, Tongue, Subthalamic Nucleus, Lymph Node, Cortex, Tonsil

Sources

Publications for Swallowing Disorders

Articles related to Swallowing Disorders:

(show top 50) (show all 1234)

#	Title	Authors	PMID	Year
1	Comparison of SaCoVLM™ video laryngeal mask-guided intubation and i-gel combined with flexible bronchoscopy-guided intubation in airway management during general anesthesia: a non-inferiority study. ⁴¹	Yan CL...Zuo MZ	36138363	2022
2	A randomized controlled study of two different fixations in anterior cervical discectomy of multilevel cervical spondylotic myelopathy. ⁴¹	Li W...Wang Y	36069629	2022
3	Effect of Cold Fluid Compensatory Swallowing Combined with Balloon Dilation on the Treatment of Poststroke Cricopharyngeal Achalasia: A Pilot Randomized Controlled Trial. ⁴¹	Li X...You X	36254140	2022
4	The role of pH-impedance monitoring in swallowing disorders. ⁶²	Bobin F...Lechien JR	36004789	2022
5	Healthy Volunteers Immediately Adapt to Submental Stimulation During Swallowing. ⁶²	Safi MF...Ludlow CL	34590756	2022
6	Nutritional risk at hospital admission is associated with prolonged length of hospital stay in old patients with COVID-19. ⁶²	Mendes A...Genton L	33933295	2022
7	New Radioprotective Device that can be Used for Fluoroscopic Exam: Possibility to Contribute to Staff Exposure Protection During VFSS. ⁶²	Morishima Y...Ito O	35169874	2022
8	The effects of tongue elevation using a weighted plastic bottle on the tongue pressure and activity of suprahyoid muscles. ⁶²	Nanto T...Domen K	36029125	2022
9	How the work of respiratory physiotherapists changes the tracheostomy management and decannulation in a NICU department: an Italian experience. ⁶²	Papi D...Bucciardini L	36426898	2022
10	Tri-lobed Tongue: Rare Manifestation Accompany With Pierre Robin Sequence. ⁶²	Merza AM...Salih HM	36319614	2022
11	Swallowing-related quality of life in children with oesophageal atresia: a national cohort study. ⁶²	Bergmann S...Lurz E	36331620	2022
12	Flexible endoscopic evaluation of swallowing in children with type 1 spinal muscular atrophy. ⁶²	Zang J...Pflug C	36209319	2022
13	High-resolution esophageal manometry in children. ⁶²	Waikar Y	36265522	2022
14	Reliability and validity of the Turkish version of speech pathology-specific questionnaire for persons with multiple sclerosis (SMS-TR). ⁶²	Erensoy I...Terzi M	36308425	2022
15	Angiotensin-converting enzyme inhibitors reduce community-acquired pneumonia hospitalization and mortality. ⁶²	Alexander DP...Munger MA	36278479	2022
16	Instrumental Swallowing Assessments in the Neonatal and Pediatric Populations: A Systematic Review. ⁶²	Christovam CA...Levy DS	34719729	2022
17	Automated pharyngeal phase detection and bolus localization in videofluoroscopic swallowing study: Killing two birds with one stone? ⁶²	Bandini A...Steele CM	35961072	2022
18	Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion. ⁶²	Malaize H...PSL BRAIN-BIOPSY STUDY GROUP	36083426	2022
19	Risk Factors for Feeding and Swallowing Disorders in Very Low Birth Weight Infants in Their Second Year of Life. ⁶²	Slana N...Kornhauser-Cerar L	36363492	2022
20	The Sheba Medical Center Protocol for Bedside Evaluation of Swallowing Disorders Among Tracheotomized Patients. ⁶²	Freud D...Henkin Y	34787704	2022
21	The effects of physiotherapy treatments on dysphagia in Parkinson's disease: A systematic review of randomized controlled trials. ⁶²	Wen X...Liu H	35882280	2022
22	Translation, Cultural Adaptation, Reliability, and Validity Evidence of the Feeding/Swallowing Impact Survey (FS-IS) to Brazilian Portuguese. ⁶²	Rama CG...Bosa VL	34779911	2022
23	Quantitative Measurement of Swallowing Performance Using Iowa Oral Performance Instrument: A Systematic Review and Meta-Analysis. ⁶²	Franciotti R...Perrotti V	36140420	2022
24	The Effect of Repetitive Transcranial Magnetic Stimulation in Synchronization with Effortful Swallowing on Post-stroke Dysphagia. ⁶²	Wen X...Wang M	36087120	2022
25	Swallowing disorders after thyroidectomy: a systematic review and meta-analysis. ⁶²	Vardaxi C...Printza A	35438344	2022
26	Egy nemzetközi nyelészavarszűrési módszer hazai adaptálása. ⁶²	Szabo PT...Balogh Z	36057872	2022
27	Clinical usefulness of transcutaneous laryngeal ultrasonography in otolaryngology practice during COVID-19 pandemic: a literature review. ⁶²	Sciancalepore PI...Quaranta N	36094753	2022
28	The Effects of Swallowing Disorders and Oral Malformations on Nutritional Status in Children with Cerebral Palsy. ⁶²	Mouilly M...El Hessni A	36079915	2022
29	Swallowing Related Problems of Toddlers with Down Syndrome. ⁶²	Serel Arslan S	36118664	2022
30	Treatment Approaches for Swallowing Disorders in Children. ⁶²	Cano-Larios MJ...Ramirez-Mayans J	36043725	2022
31	Virtual Surgical Planning and Customized Subperiosteal Titanium Maxillary Implant (CSTMI) for Three Dimensional Reconstruction and Dental Implants of Maxillary Defects after Oncological Resection: Case Series. ⁶²	Cebrian Carretero JL...Navarro Cuellar C	35956210	2022
32	Post-Cerebrovascular Stroke and Early Dysphagia Assessment: A Systematic Review. ⁶²	Maniaci A...Cocuzza S	36043981	2022
33	From DYMUS to DYPARK: Validation of a Screening Questionnaire for Dysphagia in Parkinson's Disease. ⁶²	Dagna C...DYPARK SIRN Group	34264379	2022
34	Short and Long-Term Voice and Swallowing-Related Quality of Life in Patients Who Underwent Total Laryngectomy and Tracheoesophageal Puncture. ⁶²	Marzouki HZ...Merdad M	35928174	2022
35	Detection of swallowing disorders with a multiple-channel surface electromyography sensor sheet. ⁶²	Koyama Y...Kurita H	35784131	2022
36	Swallowing disorders and associated factors in older adults living in nursing homes. ⁶²	Xavier JS...Pernambuco L	35357579	2022
37	Diagnostic Accuracy of the Eating Assessment Tool-10 (EAT-10) in Screening Dysphagia: A Systematic Review and Meta-Analysis. ⁶²	Zhang PP...Wang XW	35849209	2022
38	Automated Chicago Classification for Esophageal Motility Disorder Diagnosis Using Machine Learning. ⁶²	Surdea-Blaga T...Popa SL	35890906	2022
39	Interaction between malnutrition and physical disability in older adults: is there a malnutrition-disability cycle? ⁶²	Nishioka S...Wakabayashi H	35831980	2022
40	Efficacy of soft palatal augmentation prosthesis for oral functional rehabilitation in patients with dysarthria and dysphagia: a protocol for a randomised controlled trial. ⁶²	Yokoyama T...Minagi S	35835521	2022
41	Translation and Validation of the Indonesian MD Anderson Dysphagia Inventory (MDADI) in Head and Neck Cancer Patients with Swallowing Disorders. ⁶²	Fakhriani R...Rianto BUD	35846827	2022
42	Interprofessional Education Module on Post-Intensive Care Syndrome for Internal Medicine Residents. ⁶²	Hampton SF...Berger G	35924197	2022
43	Nutritional status in patients with advanced-stage multiple sclerosis. ⁶²	Teng M...Levy J	35152502	2022
44	Prevalence of dysphagia symptoms in Cretan children and adolescents with neurological disorders. ⁶²	Rikos N...Linardakis M	35722237	2022
45	Rice congee as an alternative to thickened liquids for patients with swallowing disorders. ⁶²	Ng ML...Lui HY	35255166	2022
46	Protocols and assessment procedures in fiberoptic endoscopic evaluation of swallowing: an updated systematic review. ⁶²	Prikladnicki A...Cardoso MC	33895102	2022
47	Application of Ultrasonography in Neurogenic Dysphagia: A Systematic Review. ⁶²	Potente P...Manganotti P	35556172	2022
48	The yield of solid swallows in high resolution esophageal manometry among patients with dysphagia and gastro-esophageal reflux symptoms. ⁶²	Mahamid R...Mari A	35388665	2022
49	Advances in Management of Voice and Swallowing Disorders. ⁶²	Speyer R	35566434	2022
50	White Paper by the European Society for Swallowing Disorders: Screening and Non-instrumental Assessment for Dysphagia in Adults. ⁶²	Speyer R...Woisard V	33787994	2022